Results of the prospective, randomized, multicenter clinical trial evaluating a biosynthesized cellulose graft for repair of dural defects

Neurosurgery

Volumn 69, Issue 5, 2011, Pages 1093-1103

  Rosen, Charles L ^a   Steinberg, Gary K ^b   Demonte, Franco ^c   Delashaw Jr , Johnny B ^d   Lewis, Stephen B ^e   Shaffrey, Mark E ^f   Aziz, Khaled ^g   Hantel, Johanna ^h   Marciano, Frederick F ⁱ  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h Johnson Johnson Company   (United States)

ⁱ HonorHealth and the Scottsdale Lincoln Health Network   (United States)

Author keywords

Allograft; Biosynthesized cellulose; Dura mater; Dural substitute; Duraplasty; Pericranium

Indexed keywords

CELLULOSE; COLLAGEN;

ADULT; AUTOGRAFT; CONTROLLED STUDY; DURA MATER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOCELE; MENINX DISORDER; MORBIDITY; MULTICENTER STUDY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCANNING ELECTRON MICROSCOPY; SKULL SURGERY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT INDICATION; WOUND CLOSURE;

ADOLESCENT; ADULT; AGED; ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELLULOSE; CRANIOTOMY; DURA MATER; FEMALE; HUMANS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PROSPECTIVE STUDIES; RECONSTRUCTIVE SURGICAL PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053640219     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3182284aca     Document Type: Review

References (19)

1. Malliti M, Page P, Gury C, Chomette E, Nataf F, Roux FX. Comparison of deep wound infection rates using a synthetic dural substitute (neuro-patch) or pericranium graft for dural closure: a clinical review of 1 year. Neurosurgery. 2004;54(3):599-603; discussion 603-594.
2. Yamada K, Miyamoto S, Nagata I, et al. Development of a dural substitute from synthetic bioabsorbable polymers. J Neurosurg. 1997;86(6):1012-1017. (Pubitemid 27230145)
3. Hoover DA, Mahmood A. Ossification of autologous pericranium used in duraplasty. Case report. J Neurosurg. 2001;95(2):350-352. (Pubitemid 32799762)
4. Laquerriere A, Yun J, Tiollier J, Hemet J, Tadie M. Experimental evaluation of bilayered human collagen as a dural substitute. J Neurosurg. 1993;78(3): 487-491. (Pubitemid 23073222)
5. Stevens EA, Powers AK, Sweasey TA, Tatter SB, Ojemann RG. Simplified harvest of autologous pericranium for duraplasty in Chiari malformation Type I. Technical note. J Neurosurg Spine. 2009;11(1):80-83.
6. Tachibana E, Saito K, Fukuta K, Yoshida J. Evaluation of the healing process after dural reconstruction achieved using a free fascial graft. J Neurosurg. 2002;96(2): 280-286. (Pubitemid 34230242)
7. Macfarlane MR, Symon L. Lyophilised dura mater: experimental implantation and extended clinical neurosurgical use. J Neurol Neurosurg Psychiatry. 1979;42(9):854-858. (Pubitemid 9245264)
8. McCall TD, Fults DW, Schmidt RH. Use of resorbable collagen dural substitutes in the presence of cranial and spinal infections-report of 3 cases. Surg Neurol. 2008;70(1):92-96; discussion 96-97.
9. Narotam PK, van Dellen JR, Bhoola KD. A clinicopathological study of collagen sponge as a dural graft in neurosurgery. J Neurosurg. 1995;82(3):406-412.
10. Von Wild KR. Examination of the safety and efficacy of an absorbable dura mater substitute (Dura Patch) in normal applications in neurosurgery. Surg Neurol. 1999;52(4):418-424; discussion 425.
11. Bejjani GK, Zabramski J. Safety and efficacy of the porcine small intestinal submucosa dural substitute: results of a prospective multicenter study and literature review. J Neurosurg. 2007;106(6):1028-1033. (Pubitemid 46871116)
12. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet.1996;347(9006):921-925.
13. Blackwelder WC. "Proving the null hypothesis" in clinical trials. Control Clin Trials. 1982;3(4):345-353. (Pubitemid 13113168)
14. Donner A. Approaches to sample size estimation in the design of clinical trials-a review. Stat Med. 1984;3(3):199-214. (Pubitemid 14037609)
15. Moskowitz SI, Liu J, Krishnaney AA. Postoperative complications associated with dural substitutes in suboccipital craniotomies. Neurosurgery. 2009;64(3 suppl):28- 33; discussion 33-24.
16. Danish SF, Samdani A, Hanna A, Storm P, Sutton L. Experience with acellular human dura and bovine collagen matrix for duraplasty after posterior fossa decompression for Chiari malformations. J Neurosurg. 2006;104(1 suppl):16-20. (Pubitemid 44954855)
17. Mello LR, Feltrin LT, Fontes Neto PT, Ferraz FA. Duraplasty with biosynthetic cellulose: an experimental study. J Neurosurg. 1997;86(1):143-150. (Pubitemid 27009986)
18. Abbott WM, Dupree EL Jr. Clinical results of lyophilized human cadaver dura transplantation. J Neurosurg. 1971;34(6):770-773.
19. CantoreG, GuidettiB,Delfini R. Neurosurgical use of human duramater sterilized by gamma rays and stored in alcohol: long-term results. J Neurosurg. 1987;66(1):93-95. (Pubitemid 17214287)